Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 1, 2015, Pages 166-171

  Ansaldi, Filippo ^a,b   Orsi, Andrea ^a   Trucchi, Cecilia ^a   De Florentiis, Daniela ^c   Ceravolo, Antonella ^a   Coppelli, Martina ^a   Schiaffino, Sergio ^d   Turello, Valter ^e   Rosselli, Roberto ^e   Carloni, Roberto ^f   Icardi, Giancarlo ^a,b   Canepa, Paola ^d   Sticchi, Laura ^d   Zanetti, Roberta ^d   Cremonesi, Ilaria ^d   Brasesco, PierClaudio ^d   Moscatelli, Paolo ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Office of Maritime Health Air and Border (USMAF)   (Italy)

^d Public Health and Vulnerable Social Groups ^*

^e ASL 3 Genovese   (Italy)

^f Regione Liguria   (Italy)

Author keywords

Hospital access; Lower respiratory tract infections; Pneumococcal vaccination; Pneumonia; Syndrome surveillance

Indexed keywords

13-VALENT PNEUMOCOCCAL VACCINE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; ITALY; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT INFECTIONS; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 84949115726     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.34419     Document Type: Conference Paper

References (40)

1. Millett ER, Quint JK, Smeeth L, Daniel RM, Thomas SL. Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS One 2013; 8:e75131; PMID:24040394; http://dx.doi.org/10.1371/journal.pone.0075131
2. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333:1618-24; PMID:7477199; http://dx.doi.org/10.1056/NEJM199512143332408
3. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, Leinonen M, Saikku P, Myint S. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56:109-14; PMID:11209098; http://dx.doi.org/10.1136/thorax.56.2.109
4. Gueli N, Martinez A, Verrusio W, Linguanti A, Passador P, Martinelli V, Longo G, Marigliano B, Cacciafesta F, Cacciafesta M. Empirical antibiotic therapy (ABT) of lower respiratory tract infections (LRTI) in the elderly: application of artificial neural network (ANN). Preliminary results. Arch Gerontol Geriatr 2012; 55:499-503; PMID:21978414; http://dx.doi.org/10.1016/j.archger.2011.09.006
5. Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 2013; 68:1057-65; PMID:24130229; http://dx.doi.org/10.1136/thoraxjnl-2013-204282
6. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67:71-9; PMID:20729232; http://dx.doi.org/10.1136/thx.2009.129502
7. WHO. Health statistics and information systems. Global Health Estimates (GHE). 20 Leading Causes of Death. Available from http://www.who.int/healthinfo/global-burden-disease/en/.
8. Hak E, Grobbee DE, Sanders EA, Verheij TJ, Bolkenbaas M, Huijts SM, Gruber WC, Tansey S, McDonough A, Thoma B, et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008; 66:378-83; PMID:18990781
9. Aliberti S, Kaye KS. The changing microbiologic epidemiology of community-acquired pneumonia. Postgrad Med 2013; 125:31-42; PMID:24200759; http://dx.doi.org/10.3810/pgm.2013.11.2710
10. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64:1062-9; PMID:19454409; http://dx.doi.org/10.1136/thx.2008.109785
11. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, Lim WS. Serotype prevalence in adults hospitalised with pneumococcal noninvasive community-acquired pneumonia. Thorax 2012; 67:540-5; PMID:22374921; http://dx.doi.org/10.1136/thoraxjnl-2011-201092
12. Marston BJ, Plouffe JF, File TM Jr., Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF; The Community-Based Pneumonia Incidence Study Group. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. Arch Intern Med 1997; 157:1709-18; PMID:9250232; http://dx.doi.org/10.1001/archinte.1997.00440360129015
13. Kornum JB, Due KM, Nørgaard M, Tjønneland A, Overvad K, Sørensen HT, Thomsen RW. Alcohol drinking and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2012; 39:149-55; PMID:21659417; http://dx.doi.org/10.1183/09031936.00000611
14. Melegaro A, Edmunds WJ, Pebody R, Miller E, George R. The current burden of pneumococcal disease in England and Wales. J Infect 2006; 52:37-48; PMID:16368459; http://dx.doi.org/10.1016/j.jinf.2005.02.008
15. Trotter CL, Stuart JM, George R, Miller E. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 2008; 14:727-33; PMID:18439353; http://dx.doi.org/10.3201/eid1405.071011
16. Monge V, González A. Hospital admissions for pneumonia in Spain. Infection 2001; 29:3-6; PMID:11261755; http://dx.doi.org/10.1007/s15010-001-0024-2
17. Gutiérrez F, Masiá M, Mirete C, Soldán B, Rodríguez JC, Padilla S, Hernández I, Royo G, Martin-Hidalgo A. The influence of age and gender on the population- based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 2006; 53:166-74; PMID:16375972; http://dx.doi.org/10.1016/j.jinf.2005.11.006
18. Ochoa-Gondar O, Vila-Córcoles A, de Diego C, Arija V, Maxenchs M, Grive M, Martin E, Pinyol JL; EVAN-65 Study Group. The burden of community- acquired pneumonia in the elderly: the Spanish EVAN-65 study. BMC Public Health 2008; 8:222; PMID:18582392; http://dx.doi.org/10.1186/1471-2458-8-222
19. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez- Blanco T, Raga-Luria X, Gomez-Bertomeu F; EPIVAC Study Group. Epidemiology of community- acquired pneumonia in older adults: a population- based study. Respir Med 2009; 103:309-16; PMID:18804355; http://dx.doi.org/10.1016/j.rmed.2008.08.006
20. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56:296-301; PMID:11254821; http://dx.doi.org/10.1136/thorax.56.4.296
21. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl 2002; 36:20s-7s; PMID:12168744; http://dx.doi.org/10.1183/09031936.02.00702002
22. Ansaldi F, Orsi A, Altomonte F, Bertone G, Parodi V, Carloni R, Moscatelli P, Pasero E, Comaschi M, Oreste P, et al. Syndrome surveillance and molecular epidemiology for early detection and tracing of an outbreak of measles in Liguria, Italy. J Med Virol 2009; 81:1807-13; http://dx.doi.org/10.1002/jmv.21584
23. De Florentiis D, Parodi V, Orsi A, Rossi A, Altomonte F, Canepa P, Ceravolo A, Valle L, Zancolli M, Piccotti E, et al. Impact of influenza during the postpandemic season: epidemiological picture from syndromic and virological surveillance. J Prev Med Hyg 2011; 52:134-6; PMID:22010543
24. Bartlett JG, Dowell SF, Mandell LA, File TM Jr., Musher DM, Fine MJ; Infectious Diseases Society of America. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31:347-82; PMID:10987697; http://dx.doi.org/10.1086/313954
25. Vinogradova Y, Coupland C, Hippisley-Cox J. Risk of pneumonia in patients taking statins: populationbased nested case-control study. Br J Gen Pract 2011; 61:e742-8; PMID:22054338; http://dx.doi.org/10.3399/bjgp11X606654
26. Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR. Statins and the risk of pneumonia: a populationbased, nested case-control study. Pharmacotherapy 2007; 27:325-32; PMID:17316144; http://dx.doi.org/10.1592/phco.27.3.325
27. Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 2009; 18:269-75; PMID:19235776; http://dx.doi.org/10.1002/pds.1715
28. Teepe J, Grigoryan L, Verheij TJ. Determinants of community-acquired pneumonia in children and young adults in primary care. Eur Respir J 2010; 35:1113-7; PMID:20436174; http://dx.doi. org/10.1183/09031936.00101509
29. Schnoor M, Klante T, Beckmann M, Robra BP, Welte T, Raspe H, Schäfer T; CAPNETZ Study Group. Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 2007; 135:1389-97; PMID:17291378; http://dx.doi.org/10.1017/S0950268807007832
30. van de Garde EM, Hak E, Souverein PC, Hoes AW, van den Bosch JM, Leufkens HG. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 2006; 61:957-61; PMID:16809409; http://dx.doi.org/10.1136/thx.2006.062885
31. Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A; Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 2008; 31:1274-84; PMID:18216057; http://dx.doi.org/10.1183/09031936.00095807
32. Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 2009; 59:e329-38; PMID:19843413; http://dx.doi.org/10.3399/bjgp09X472629
33. Rodríguez LA, Ruigómez A, Wallander MA, Johansson S. Acid-suppressive drugs and communityacquired pneumonia. Epidemiology 2009; 20:800-6; PMID:19797970; http://dx.doi.org/10.1097/EDE.0b013e3181b5f27d
34. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008; 31:1541-5; PMID:18487479; http://dx.doi.org/10.2337/dc08-0138
35. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 2007; 30:2251-7; PMID:17595354; http://dx.doi.org/10.2337/dc06-2417
36. Ansaldi F, Orsi A, Altomonte F, Bertone G, Parodi V, Carloni R, Moscatelli P, Pasero E, Oreste P, Icardi G. Emergency department syndromic surveillance system for early detection of 5 syndromes: a pilot project in a reference teaching hospital in Genoa, Italy. J Prev Med Hyg 2008; 49:131-5; PMID:19350960
37. Zoppi G, Trucchi C. Investigation on seasonal influenza vaccination among children with highrisk medical conditions who live in the area of Local Health Agency 4 "Chiavarese". J Prev Med Hyg 2011; 52:148-50; PMID:22010547
38. Regional Health Agency. Nocchiero project. Italian. Available from: http://www.arsliguria.it/index.php?option=com-content&view=article&id=691&Itemid=283.
39. National Immunization Prevention Plan 2012 - 2014. Gazzetta Ufficiale. n. 60. 12 Mar 2012. Italian. Available from: http://www.salute.gov.it/imgs/C-17-pubblicazioni-1721-allegato.pdf.
40. Region L. Department of Public Health and Social Services. Prevenzione della malattia pneumococcica negli adulti con età superiore a 64 anni e nei giovani adulti con fattori di rischio - istruzioni operative. Prot. n. PG/2013/11235. Italian. Available from: www.liguriainformasalute.it.